Literature DB >> 15513407

Successful treatment of pulmonary mucormycosis in an allogenic bone-marrow transplant recipient with combined medical and surgical therapy.

Juliette Pavie1, Matthieu Lafaurie, Claire Lacroix, Anne Marie Zagdanski, Denis Debrosse, Gérard Socié, Francis Derouin, Eliane Gluckman, Jean Michel Molina.   

Abstract

Mucormycosis is a rare, but severe, complication in allogenic bone-marrow recipients with a mortality rate of about 80%. Moreover, its incidence appears to have increased within the last decade. We report a case of pulmonary and nasal mucormycosis in a 55-y-old patient, which occurred 1 y after BMT. Treatment combining 4 months of amphotericin B, early surgical resection of infected tissue and discontinuation of immunosuppressive treatment allowed the cure of this mould infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15513407     DOI: 10.1080/00365540410021081

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  10 in total

1.  Gastrointestinal mucormycosis: an evolving disease.

Authors:  Brad Spellberg
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-02

Review 2.  Zygomycosis: the re-emerging fungal infection.

Authors:  M Chayakulkeeree; M A Ghannoum; J R Perfect
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

3.  Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients.

Authors:  Shingo Yano; Jiro Minami; Kaichi Nishiwaki; Takaki Shimada; Nobuaki Dobashi; Yuichi Yahagi; Yutaka Takei; Shinobu Takahara; Yoji Ogasawara; Katsuki Sugiyama; Yuko Yamaguchi; Takeshi Saito; Kinuyo Kasama; Hiroki Yokoyama; Tomohito Machishima; Atsushi Katsube; Noriko Usui; Keisuke Aiba
Journal:  Int J Hematol       Date:  2011-03-02       Impact factor: 2.490

Review 4.  Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

Authors:  Brad Spellberg; John Edwards; Ashraf Ibrahim
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

5.  The rise of an opportunistic infection called "Invasive Zygomycosis".

Authors:  Abdelkarim Waness; Ghuzayel Al Dawsari; Hamdan Al Jahdali
Journal:  J Glob Infect Dis       Date:  2009-07

6.  Recent advances in the treatment of mucormycosis.

Authors:  Brad Spellberg; Ashraf S Ibrahim
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

Review 7.  Recent advances in the management of mucormycosis: from bench to bedside.

Authors:  Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis; John Edwards; Ashraf S Ibrahim
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

Review 8.  Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.

Authors:  Asim Azhar; Wajihul Hasan Khan; Parvez Anwar Khan; Khaled Alhosaini; Mohammad Owais; Aijaz Ahmad
Journal:  J Infect Public Health       Date:  2022-02-18       Impact factor: 3.718

9.  Pulmonary mucormycosis: A case report and review of the literature.

Authors:  Xi-Ming Wang; Ling-Chuan Guo; Sheng-Li Xue; Yan-Bin Chen
Journal:  Oncol Lett       Date:  2016-03-22       Impact factor: 2.967

10.  Rare complication of bronchoesophageal fistula due to pulmonary mucormycosis after induction chemotherapy for acute myeloid leukemia: a case report.

Authors:  Jun-Hyung Lee; Jin-Soo Hyun; Da-Yeong Kang; Hee-Jeong Lee; Sang-Gon Park
Journal:  J Med Case Rep       Date:  2016-07-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.